The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 15,659 | 377,777 | SH | SOLE | 377,777 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 14,376 | 112,363 | SH | SOLE | 112,363 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,265 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 31,367 | 548,374 | SH | SOLE | 548,374 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 7,788 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 2,813 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 15,160 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 10,975 | 430,041 | SH | SOLE | 430,041 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 1,629 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| CALLIDITAS THERAPEUTICS AB | SPONSERED ADS | 13124Q106 | 6,724 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 11,694 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 18,245 | 1,041,398 | SH | SOLE | 1,041,398 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 13,937 | 225,076 | SH | SOLE | 225,076 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 18,018 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 10,112 | 481,538 | SH | SOLE | 481,538 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 5,416 | 146,014 | SH | SOLE | 146,014 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 15,116 | 1,563,138 | SH | SOLE | 1,563,138 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,548 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 21,432 | 454,550 | SH | SOLE | 454,550 | 0 | 0 | ||
| INVENTIVA SA | ADS | 46124U107 | 2,900 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,699 | 680,036 | SH | SOLE | 680,036 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 3,090 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 1,802 | 434,114 | SH | SOLE | 434,114 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 5,217 | 295,238 | SH | SOLE | 295,238 | 0 | 0 | ||
| KRONOS BIO INC | COM | 50107A104 | 4,366 | 146,173 | SH | SOLE | 146,173 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 4,899 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 2,279 | 75,227 | SH | SOLE | 75,227 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 15,378 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 4,994 | 126,136 | SH | SOLE | 126,136 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 8,504 | 320,440 | SH | SOLE | 320,440 | 0 | 0 | ||
| VIELA BIO INC | COM | 926613100 | 3,072 | 85,409 | SH | SOLE | 85,409 | 0 | 0 | ||